Insights

Our investment priorities in 2026

February 2, 2026

We recognize that we’re at a pivotal moment in health care, where employers are facing cost pressures, employees are demanding greater choice and affordability, and technology and pharmaceutical innovations are rapidly accelerating. As a strategic investor focused on improving the quality, affordability and equity of employer-sponsored insurance, Morgan Health is dedicated to scaling solutions that address critical needs across employers of all sizes – and more work remains.

Morgan Health is sharpening its focus on investing in companies that deliver flexibility and transparency to employers and employees alike. In 2026, we're directing our investments toward five key areas:

New coverage options

Employers are increasingly seeking plan designs that offer greater flexibility and value, moving beyond traditional health insurance and creating opportunities to innovate in this space. This is particularly true for our nation’s small- and mid-sized businesses – which increasingly report that rising premium costs put them at a competitive disadvantage and detract from their ability to hire talent and grow their business. With more of these businesses considering and/or adopting alternative health plans, there's a significant opportunity in this space. We are focused on opportunities to stabilize costs without sacrificing quality – based on the early success we’ve observed with Centivo (a primary care-led health plan) and Venteur (an ICHRA provider). On average, Centivo helps save employers 15 to 30% on health insurance and we’re encouraged by the response and engagement we’ve seen to “SF Chamber Care” – a new offering from Venteur offered through the SF Chamber of Commerce.

  • Current investments: Centivo, Venteur
  • Future investments: Solutions focused on variable copay plan designs and integrated cost containment

Pharmacy management

With the rapid development in high-cost, life-changing therapies, employers and patients urgently need pharmacy management solutions that balance affordability and access to these medications. Building on our most recent investment in Aradigm Health, Morgan Health is focused on further scaling pharmacy management solutions that address the needs of working-age individuals, especially those who rely on specialty drugs and cell and gene therapies. We look forward to supporting Aradigm’s first product roll-out for the employer market this April. Our goal is to help employers offer access to these innovative therapies at a reasonable and sustainable cost.

  • Current investments: Aradigm Health, Fuze Health
  • Potential investments: Solutions to manage specialty Rx costs, including transparent models

Specialty care

Patients living with complex health conditions and their families are often forced to navigate a complex maze of health care providers and treatment plans, leading to suboptimal outcomes and an unideal experience. Morgan Health is focused on sourcing and scaling solutions that simplify the care journey for high-burden conditions, providing a pathways for patients receive coordinated and high-quality support. By expanding access to coordinated specialty care, we aim to enhance outcomes for patients and better support caregivers. As one recent example, our portfolio company Cortica recently secured a national value-based contract with Aetna, making coordinated pediatric autism and neurodiverse care accessible for Aetna’s commercial members nationwide.

  • Current investments: Cortica, Thyme Care
  • Potential investments: Solutions that enable virtual and/or in-home care for individuals with unique health care needs

Data analytics

Recently, there’s been a surge in the number of Americans turning to AI for health insurance questions. This underscores a shift in behavior: patients want access to real-time data and reliable information to improve their health care decision-making. As such, Morgan Health is committed to investing in companies that arm patients with data – and empower them to better navigate their care. By making reliable data more usable and accessible, we aim to enhance member engagement, satisfaction and health outcomes. Our portfolio company Embold is making strides in this space. They’re making it easier for employers to help their people connect with high-quality, affordable care. Their interactive Provider Guide helped large, self-insured companies – covering over 325,000 employees – cut costs by nearly 5.5% per member per year.

  • Current investments: Embold Health, Merative
  • Potential investments: Data-backed solutions that help patients directly identify and access high-quality providers, particularly in complex and specialty areas

Primary care & care navigation

Better health outcomes rely on reliable access to a quality health care provider. Without an established provider relationship, patients often face obstacles in accessing the necessary information and support to manage and coordinate their conditions – increasing the need for additional care or even hospitalizations down the road. We’re committed to advancing models that help patients get the right care at the right time. Advanced primary care is one key example. Morgan Health was an early champion and adopter in this space, and we are committed to being transparent in open sourcing our learnings with other employers to help maximize their offerings. Our key takeaway: Clinical outcomes and cost savings take time, but employers should stay the course.

  • Current investments: Mosaic Health, Personify Health
  • Potential investments: Solutions that offer personalized, omnichannel care